Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone injection for opioid-induced constipation in advanced disease patients
CTR20150290Phase 2Terminated
- Sponsor
- Furikangzheng Medical Technology
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Furikangzheng Medical Technology. Started Jul 2015; status: terminated.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on CTR20150290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150290.